Matches in Nanopublications for { ?s ?p "[Specific inhibitors against BCR-ABL, such as Imatinib mesylate (IM), have greatly improved CML management; however, no single agent is a cure yet.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- assertion description "[Specific inhibitors against BCR-ABL, such as Imatinib mesylate (IM), have greatly improved CML management; however, no single agent is a cure yet.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1295505.RACG0Fa2ejRcp4DLkUKq4T7e9chSavHrFwXJy7_UiAvRw130_assertion description "[Specific inhibitors against BCR-ABL, such as Imatinib mesylate (IM), have greatly improved CML management; however, no single agent is a cure yet.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1295505.RACG0Fa2ejRcp4DLkUKq4T7e9chSavHrFwXJy7_UiAvRw130_provenance.